Cyclophosphamide for Injection, USP
XGen Pharmaceuticals DJB, Inc. is pleased to announce the addition of Cyclophosphamide for Injection, USP to their expanding product line. Cyclophosphamide for Injection will be available with a 3 year shelf-life in single-dose vials each containing 500 milligrams, 1 gram or 2 grams of lyophilized powder, individually packaged as 1 vial per carton under NDC 39822-0250-1, NDC 39822-0255-1, or NDC 39822-0260-1, respectively.
“As a reliable provider of affordable and necessary generic drug products, we are excited to be launching our Cyclophosphamide for Injection product into the U.S. market.” stated Edmund Vanderbeck, President of XGen Pharmaceuticals, DJB. “This achievement marks the 3rd product launched by XGen DJB in the last year – pursuing our declared promise to develop and deliver specialty pharmaceutical products to better serve the healthcare community.”
For additional information and full prescribing information for Cyclophosphamide for Injection, USP – visit https://dailymed.nlm.nih.gov/dailymed/